Your browser doesn't support javascript.
loading
Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial.
Pineda, Estela; Salud, A; Vila-Navarro, E; Safont, M J; Llorente, Beatriz; Aparicio, J; Vera, R; Escudero, P; Casado, E; Bosch, C; Bohn, U; Pérez-Carrión, R; Carmona, A; Ayuso, J R; Ripollés, T; Bouzas, R; Gironella, M; García-Albéniz, X; Feliu, J; Maurel, J.
Afiliación
  • Pineda E; 1 Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.
  • Salud A; 2 Department of Medical Oncology, Arnau de Vilanova Hospital, Lleida, Spain.
  • Vila-Navarro E; 3 Department of Gastrointestinal and Pancreatic Oncology, CIBERehd-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-Clínic Hospital, Barcelona, Spain.
  • Safont MJ; 4 Department of Medical Oncology, General University Hospital of Valencia, Valencia, Spain.
  • Llorente B; 5 Department of Medical Oncology, Hospital Universitario de Burgos, Spain.
  • Aparicio J; 6 Department of Medical Oncology, La Fe University Hospital, Valencia, Spain.
  • Vera R; 7 Department of Medical Oncology, De Navarra Hospital, Pamplona, Spain.
  • Escudero P; 8 Department of Medical Oncology, Lozano Blesa Hospital, Zaragoza, Spain.
  • Casado E; 9 Department of Medical Oncology, Infanta Sofía Hospital, Madrid, Spain.
  • Bosch C; 10 Department of Medical Oncology, Pesset Hospital, Valencia, Spain.
  • Bohn U; 11 Department of Medical Oncology, Doctor Negrin University Hospital of Gran Canaria, Las Palmas de Gran Canaria, Spain.
  • Pérez-Carrión R; 12 Department of Medical Oncology, Hospital Universitario Quirón Madrid, Madrid, Spain.
  • Carmona A; 13 Department of Medical Oncology, Morales Meseguer University Hospital, Murcia, Spain.
  • Ayuso JR; 14 Department of Radiology, Hospital Clinic of Barcelona, Barcelona, Spain.
  • Ripollés T; 15 Department of Radiology, Pesset Hospital, Valencia, Spain.
  • Bouzas R; 16 Department of Radiology, Hospital Alvaro Cunqueiro, Vigo, Spain.
  • Gironella M; 3 Department of Gastrointestinal and Pancreatic Oncology, CIBERehd-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-Clínic Hospital, Barcelona, Spain.
  • García-Albéniz X; 17 Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Feliu J; 18 Department of Medical Oncology, La Paz University Hospital, Madrid, Spain.
  • Maurel J; 1 Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.
Tumour Biol ; 39(6): 1010428317705509, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28621236
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Factor de Crecimiento de Hepatocito / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Factor A de Crecimiento Endotelial Vascular / Neovascularización Patológica Tipo de estudio: Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Tumour Biol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: España Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Factor de Crecimiento de Hepatocito / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Factor A de Crecimiento Endotelial Vascular / Neovascularización Patológica Tipo de estudio: Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Tumour Biol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: España Pais de publicación: Países Bajos